Tools
ToolsPerez De Arenaza, Diego, Flather, Marcus D., Shibata, Marcelo C. and Bakhai, Ameet (2001) Systematic Review of Hirudin in Acute Coronary Syndromes and Percutaneous Coronary Intervention. Current Interventional Cardiology Reports, 3 (2). pp. 156-162. ISSN 1523-3839
Full text not available from this repository. (Request a copy)Abstract
Thrombin plays a key role in the pathogenesis of acute coronary syndromes because it is a potent platelet agonist and converts fibrinogen to fibrin. Hirudin is a powerful, direct, and specific antithrombin agent that can be used in many therapeutic scenarios in which heparin is routinely used. In this systemic review, we summarize evidence from randomized clinical trials evaluating the benefits and risks of recombinant hirudin for the treatment of acute coronary syndromes and patients undergoing percutaneous coronary intervention.
| Item Type: | Article |
|---|---|
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) |
| Depositing User: | Pure Connector |
| Date Deposited: | 20 Jan 2014 16:18 |
| Last Modified: | 11 Sep 2021 23:50 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/46309 |
| DOI: |
Actions (login required)
 |
View Item |